The comprehensive vascular screening was performed in five women with NF1 (11.4%) because of additional risk factors for vascular complications, such as obesity or a family history of cardiovascular complications (data not shown). This evidence concerns the gene NF1 and obesity due to melanocortin 4 receptor deficiency.